Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: Comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET

Molecular Genetics and Metabolism

Volumn 80, Issue 3, 2003, Pages 350-355

  Silverman, Daniel H S ^a,b   Truong, Co T ^a   Kim, Shanna K ^a   Chang, Carol Y ^a   Chen, Wei ^b   Kowell, Arthur P ^a   Cummings, Jeffrey L ^a   Czernin, Johannes ^a,b   Small, Gary W ^b   Phelps, Michael E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Cerebral metabolism; Dementia; FDG; MMSE; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN OXYGEN CONSUMPTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; EVALUATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MINI MENTAL STATE EXAMINATION; PATIENT CODING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM;

EID: 0142247213     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-7192(03)00139-2     Document Type: Article

References (10)

1. Evans D.A. Estimated prevalence of Alzheimer's disease in the US. Milbank Q. 68:1990;267-289.
2. R. Koppel, Alzheimer's disease: the costs to U.S. businesses in 2002, Alzheimer's Association, Chicago IL, 2002, pp. 1-29. Available from www.alz.org.
3. Ernst R.L., Hay J.W. The U.S. economic and social costs of Alzheimer's disease revisited. Am. J. Pub. Health. 84:1994;1261-1264.
4. National Institute on Aging. Progress report on Alzheimer's disease. NIH Publication No. 96-4137. National Institute of Aging, Bethesda, MD, 1996, p. 4137.
5. Silverman D.H.S., Phelps M.E. Application of positron emission tomography for evaluation of metabolism and blood flow in human brain: normal development, aging, dementia, and stroke. Mol. Genet. Metab. 74:2001;128-138. doi: 10.1006/mgme.2001.3236.
6. Minoshima S., Giordani B., Berent S., Frey K., Foster N.L., Kuhl D.E. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann. Neurol. 42:1997;85-94.
7. Herholz K., Nordberg A., Salmon E., Perani D., Kessler J., Mielke R., Halber M., Jelic V., Almkvist O., Collette F., Alberoni M., Kennedy A., Hasselbalch S., Fazio F., Heiss W.D. Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 10:1999;494-504.
8. Silverman D.H.S., Small G.W., Chang C.C.et al. Positron emission tomography in the evaluation of dementia. JAMA. 286:2001;2120-2127.
9. Silverman D.H., Kim S., Chang C., Lu C., Chen W., Czernin J., Phelps M. Prognostic value of brain PET in patients undergoing dementia evaluation: Comparing to a quantifying parameter of subsequent cognitive performance. J. Nucl. Med. 42:2001;. 60P.
10. Small G.W., Ercoli L.M., Silverman D.H.S., Huang S.-C., Komo S., Bookheimer S.Y., Lavretsky H., Miller K., Siddarth P., Mazziotta J.C., Saxena S., Wu H.M., Mega M.S., Cummings J.L., Saunders A.M., Pericak-Vance M.A., Roses A.D., Barrio J.R., Phelps M.E. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 97:2000;6037-6042.